PUBLISHER: KBV Research | PRODUCT CODE: 1635221
PUBLISHER: KBV Research | PRODUCT CODE: 1635221
North America Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile based Applications, Sensors, and Other Type), By Clinical Practice, By End Use, By Country and Growth Forecast, 2024 - 2031
The North America Psychiatric Digital Biomarkers Market would witness market growth of 23.5% CAGR during the forecast period (2024-2031).
The US market dominated the North America Psychiatric Digital Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,015.2 million by 2031. The Canada market is expected to witness a CAGR of 26.2% during (2024 - 2031). Additionally, The Mexico market would register a CAGR of 25.1% during (2024 - 2031).
Psychiatric digital biomarkers are objective, quantifiable physiological, behavioral, or digital data points that can be collected and analyzed to assess an individual's mental health. They are derived from digital devices, such as smartphones, wearables, or other connected technologies, and they offer insights into mental health conditions such as schizophrenia, anxiety, bipolar disorder, and melancholy. These biomarkers are revolutionizing mental health care by enabling real-time monitoring, early detection, and personalized treatment of psychiatric disorders. The psychiatric digital biomarkers market is emerging as a transformative frontier in mental health care, addressing longstanding challenges in the diagnosis, treatment, and monitoring of psychiatric disorders.
Digital biomarkers are quantifiable physiological or behavioral data collected through digital devices such as smartphones, wearables, or other connected technologies. In psychiatry, these biomarkers include heart rate variability, sleep patterns, physical activity levels, speech patterns, facial expressions, and social media behavior. These data points, often collected continuously and in real-time, provide a comprehensive view of an individual's mental state that traditional clinical observations may miss. By leveraging advanced analytics, including artificial intelligence (AI) and machine learning (ML), these biomarkers can detect subtle changes in mental health status, predict the onset of disorders, and monitor treatment efficacy with unprecedented precision.
The Pan American Health Organization (PAHO) highlights in its Mental Health Profile report that mental, neurological, and substance use disorders, along with suicide (MNSS), collectively account for 19% of all disability-adjusted life years (DALYs) and 34% of all years lived with disability in Mexico. The report reveals gender disparities, with alcohol use disorders, headaches, and Alzheimer's disease disproportionately affecting men, while depressive disorders, dementias, headaches, and Alzheimer's disease impact women more severely.
These statistics underscore the critical need for innovative psychiatric digital biomarkers to facilitate early identification and intervention for mental health conditions. By enabling timely and precise screening, these tools can significantly enhance access to appropriate care and support, addressing the region's unmet mental health care needs. As a result, North America is poised to offer substantial growth opportunities for the psychiatric digital biomarkers market.
Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors, and Other Type. Based on Clinical Practice, the market is segmented into Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers, and Other Clinical Practice. Based on End Use, the market is segmented into Healthcare Companies, Healthcare Providers, Payers, and Other End Use. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Canary Speech, Inc
- Sonde Health, Inc. (Puretech Health Plc)
- Koneksa Health Inc.
- Empatica Inc.
- VivoSense, Inc.
- IXICO Plc
- Neurotrack Technologies, Inc.
- Winterlight Labs
- Aural Analytics, Inc. (Linus Health)
North America Psychiatric Digital Biomarkers Market Report Segmentation
By Type
- Wearable
- Mobile based Applications
- Sensors
- Other Type
By Clinical Practice
- Diagnostic Psychiatric Digital Biomarkers
- Monitoring Psychiatric Digital Biomarkers
- Predictive and Prognostic Psychiatric Digital Biomarkers
- Other Clinical Practice
By End Use
- Healthcare Companies
- Healthcare Providers
- Payers
- Other End Use
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Psychiatric Digital Biomarkers Market, by Type
- 1.4.2 North America Psychiatric Digital Biomarkers Market, by Clinical Practice
- 1.4.3 North America Psychiatric Digital Biomarkers Market, by End Use
- 1.4.4 North America Psychiatric Digital Biomarkers Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. North America Psychiatric Digital Biomarkers Market by Type
- 4.1 North America Wearable Market by Country
- 4.2 North America Mobile based Applications Market by Country
- 4.3 North America Sensors Market by Country
- 4.4 North America Other Type Market by Country
Chapter 5. North America Psychiatric Digital Biomarkers Market by Clinical Practice
- 5.1 North America Diagnostic Psychiatric Digital Biomarkers Market by Country
- 5.2 North America Monitoring Psychiatric Digital Biomarkers Market by Country
- 5.3 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
- 5.4 North America Other Clinical Practice Market by Country
Chapter 6. North America Psychiatric Digital Biomarkers Market by End Use
- 6.1 North America Healthcare Companies Market by Country
- 6.2 North America Healthcare Providers Market by Country
- 6.3 North America Payers Market by Country
- 6.4 North America Other End Use Market by Country
Chapter 7. North America Psychiatric Digital Biomarkers Market by Country
- 7.1 US Psychiatric Digital Biomarkers Market
- 7.1.1 US Psychiatric Digital Biomarkers Market by Type
- 7.1.2 US Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.1.3 US Psychiatric Digital Biomarkers Market by End Use
- 7.2 Canada Psychiatric Digital Biomarkers Market
- 7.2.1 Canada Psychiatric Digital Biomarkers Market by Type
- 7.2.2 Canada Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.2.3 Canada Psychiatric Digital Biomarkers Market by End Use
- 7.3 Mexico Psychiatric Digital Biomarkers Market
- 7.3.1 Mexico Psychiatric Digital Biomarkers Market by Type
- 7.3.2 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.3.3 Mexico Psychiatric Digital Biomarkers Market by End Use
- 7.4 Rest of North America Psychiatric Digital Biomarkers Market
- 7.4.1 Rest of North America Psychiatric Digital Biomarkers Market by Type
- 7.4.2 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.4.3 Rest of North America Psychiatric Digital Biomarkers Market by End Use
Chapter 8. Company Profiles
- 8.1 Canary Speech, Inc.
- 8.1.1 Company Overview
- 8.1.2 SWOT Analysis
- 8.2 Sonde Health, Inc. (Puretech Health Plc)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Research & Development Expenses
- 8.2.4 Recent strategies and developments:
- 8.2.4.1 Partnerships, Collaborations, and Agreements:
- 8.2.4.2 Product Launches and Product Expansions:
- 8.2.5 SWOT Analysis
- 8.3 Koneksa Health Inc.
- 8.3.1 Company Overview
- 8.4 Empatica Inc.
- 8.4.1 Company Overview
- 8.5 VivoSense, Inc.
- 8.5.1 Company Overview
- 8.6 IXICO plc
- 8.6.1 Company Overview
- 8.7 Neurotrack Technologies, Inc.
- 8.7.1 Company Overview
- 8.8 WinterLight Labs
- 8.8.1 Company Overview
- 8.9 Aural Analytics, Inc. (Linus Health)
- 8.9.1 Company Overview
LIST OF TABLES
- TABLE 1 North America Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 2 North America Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 3 North America Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 4 North America Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 5 North America Wearable Market by Country, 2020 - 2023, USD Million
- TABLE 6 North America Wearable Market by Country, 2024 - 2031, USD Million
- TABLE 7 North America Mobile based Applications Market by Country, 2020 - 2023, USD Million
- TABLE 8 North America Mobile based Applications Market by Country, 2024 - 2031, USD Million
- TABLE 9 North America Sensors Market by Country, 2020 - 2023, USD Million
- TABLE 10 North America Sensors Market by Country, 2024 - 2031, USD Million
- TABLE 11 North America Other Type Market by Country, 2020 - 2023, USD Million
- TABLE 12 North America Other Type Market by Country, 2024 - 2031, USD Million
- TABLE 13 North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 14 North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 15 North America Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
- TABLE 16 North America Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
- TABLE 17 North America Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
- TABLE 18 North America Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
- TABLE 19 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
- TABLE 20 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
- TABLE 21 North America Other Clinical Practice Market by Country, 2020 - 2023, USD Million
- TABLE 22 North America Other Clinical Practice Market by Country, 2024 - 2031, USD Million
- TABLE 23 North America Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 24 North America Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 25 North America Healthcare Companies Market by Country, 2020 - 2023, USD Million
- TABLE 26 North America Healthcare Companies Market by Country, 2024 - 2031, USD Million
- TABLE 27 North America Healthcare Providers Market by Country, 2020 - 2023, USD Million
- TABLE 28 North America Healthcare Providers Market by Country, 2024 - 2031, USD Million
- TABLE 29 North America Payers Market by Country, 2020 - 2023, USD Million
- TABLE 30 North America Payers Market by Country, 2024 - 2031, USD Million
- TABLE 31 North America Other End Use Market by Country, 2020 - 2023, USD Million
- TABLE 32 North America Other End Use Market by Country, 2024 - 2031, USD Million
- TABLE 33 North America Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
- TABLE 34 North America Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
- TABLE 35 US Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 36 US Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 37 US Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 38 US Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 39 US Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 40 US Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 41 US Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 42 US Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 43 Canada Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 44 Canada Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 45 Canada Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 46 Canada Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 47 Canada Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 48 Canada Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 49 Canada Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 50 Canada Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 51 Mexico Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 52 Mexico Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 53 Mexico Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 54 Mexico Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 55 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 56 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 57 Mexico Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 58 Mexico Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 59 Rest of North America Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 60 Rest of North America Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 61 Rest of North America Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 62 Rest of North America Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 63 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 64 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 65 Rest of North America Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 66 Rest of North America Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 67 Key Information - Canary Speech, Inc.
- TABLE 68 Key Information - Sonde Health, Inc.
- TABLE 69 Key Information - Koneksa Health Inc.
- TABLE 70 Key Information - Empatica Inc.
- TABLE 71 Key Information - VivoSense, Inc.
- TABLE 72 Key Information - IXICO plc
- TABLE 73 Key Information - Neurotrack Technologies, Inc.
- TABLE 74 Key Information - WinterLight Labs
- TABLE 75 Key Information - Aural Analytics, Inc.
